Northeast Ohio Medical University

Study led by Akron Children's finds pro2cool's hypothermic therapy reduces adolescent concussion symptoms

Retrieved on: 
Tuesday, April 2, 2024
RN, Brain, Head, Medicine, Concussion, Ageing, Dayton Children's Hospital, Research, University, Doctor of Philosophy, University of Michigan, Frank R. McNinch, Adolescence, E pluribus unum, Hospital, Pain, Ice, Food, Swelling, FDA, Northeast Ohio Medical University, Parent, Neck, Sports medicine, Medical device

AKRON, Ohio, April 2, 2024 /PRNewswire/ -- Researchers at Akron Children's, Cincinnati Children's, University of Michigan and Dayton Children's Hospital, have found that hypothermic therapy reduces symptom severity after concussion.

Key Points: 
  • AKRON, Ohio, April 2, 2024 /PRNewswire/ -- Researchers at Akron Children's, Cincinnati Children's, University of Michigan and Dayton Children's Hospital, have found that hypothermic therapy reduces symptom severity after concussion.
  • After a second treatment using the pro2cool® system, SCAT5 scores were 25% lower than those receiving standard concussion care.
  • It is the first and only concussion treatment study of this population, and the largest single concussion therapy trial known to date.
  • Now, in addition to brain rest, concussion symptoms can be treated with selective hypothermic therapy.

EmVenio Research adds principal investigators to research team

Retrieved on: 
Tuesday, August 1, 2023
Vaccine, Emory University, Endometriosis, Bachelor of Science in Human Biology, College, Diabetes, Internal medicine, Youngstown, Ohio, The College of Medicine, Nephrology, American Board of Internal Medicine, MT, Chapel Hill, Medical school, Medical Association of Georgia, Youngstown State University, Research, Oregon Health & Science University, Medicine, Infection, Certification, Bachelor of Arts in Clinical Psychology, Chemistry, American Board of Commissioners for Foreign Missions, Alaska Federal Health Care Access Network, Kidney, Patient, University, Anemia, University of North Carolina School of Law, Northeast Ohio Medical University, Uterine fibroid, California Community College Athletic Association, Obstetrics, Knowledge, Pharmacology, Medical device, Nursing, Science, DRS

DURHAM, N.C., Aug. 1, 2023 /PRNewswire/ -- Clinical research organization EmVenio Research recently announced the addition of Dr. Stephen Blank, M.D., and Dr. Suzanne Swan, M.D., to its team, serving as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible results, as well as manage oversight of compliance, financial, personnel and other related aspects of research projects. Coming from varying medical backgrounds, Dr. Blank and Dr. Swan offer a diversity of expertise, expanding EmVenio's ability to conduct a wider range of clinical trials.

Key Points: 
  • DURHAM, N.C., Aug. 1, 2023 /PRNewswire/ -- Clinical research organization EmVenio Research recently announced the addition of Dr. Stephen Blank, M.D., and Dr. Suzanne Swan, M.D., to its team, serving as principal investigators.
  • Stephen Blank and Suzanne Swan to its team of principal investigators.
  • Blank and Swan bring to our team a magnitude of experience and knowledge in the research of new treatments and therapies," said Thad Wolfram, EmVenio president.
  • "With their diverse backgrounds in medicine, they offer a unique level of oversight to the studies EmVenio conducts and provide our organization the depth to conduct a wider range of clinical research studies for pharmaceutical and clinical research organizations."

Bend Health Promotes Amit Parikh, M.D. to Chief Medical Officer

Retrieved on: 
Thursday, June 29, 2023
Ohio State University, Depression, Tic disorder, Nationwide Children's Hospital, Attention deficit hyperactivity disorder predominantly inattentive, Patient, Anxiety, ADHD, Ventura County Medical Center, DSM-IV codes, Medical school, Abnormal psychology, CMO, Mental, Child, Bend, Northeast Ohio Medical University, Adolescence, Nation, Growth, Hospital, AI, Trauma, Mental health, Nursing

MADISON, Wis., June 29, 2023 /PRNewswire/ -- Bend Health, Inc. ("Bend"), a leading national, virtual pediatric behavioral care provider, today announced the promotion of Amit Parikh, M.D., to chief medical officer (CMO) in support of its next phase of growth.

Key Points: 
  • MADISON, Wis., June 29, 2023 /PRNewswire/ -- Bend Health, Inc. ("Bend"), a leading national, virtual pediatric behavioral care provider, today announced the promotion of Amit Parikh, M.D., to chief medical officer (CMO) in support of its next phase of growth.
  • Bend Health Promotes Amit Parikh, M.D.
  • to Chief Medical Officer
    "As a physician leader, Amit is well-versed in identifying and implementing data-driven solutions that promote patient-centered care for children and teens," said Kurt Roots, co-founder and chief executive officer, Bend Health.
  • As CMO, Dr. Parikh will lead the development and scaling of the company's unique pediatric digital behavioral health services.

Enhanced Ultrasound Superior to MRI for Diagnosing Certain Liver and Kidney Tumors, According to New Studies

Retrieved on: 
Tuesday, February 21, 2023
Medical Devices, Hospitals, FDA, Clinical Trials, Health Technology, Cardiology, Biotechnology, Radiology, Health, Oncology, Medical school, Radiation, University, ICUS, Kidney disease, Sulfur hexafluoride, Diagnosis, Urology, Journal of Ultrasound in Medicine, Character, GE HealthCare, Anxiety, Malignancy, Gastroenterology, Journal, AASLD, CEUS, Patient, MRI, CT, Liver, American Association of Clinical Endocrinologists, Contrast-enhanced ultrasound, Liver cancer, JUM, Northeast Ohio Medical University, Cancer, Neoplasm, Hepatology, Medical imaging, Medical device, Veterinary medicine, Dietary supplement, Definity, Medicine

Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the Journal of Ultrasound in Medicine (JUM) and highlighted by the International Contrast Ultrasound Society (ICUS).

Key Points: 
  • Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the Journal of Ultrasound in Medicine (JUM) and highlighted by the International Contrast Ultrasound Society (ICUS).
  • She called upon the American Association for the Study of Liver Diseases (AASLD) to include CEUS in its liver imaging guidelines, along with MRI and CT.
  • The Canadian liver study represents the first prospective comparison of CEUS and contrast-enhanced MRI for assessment of newly-discovered liver nodules, according to Dr. Wilson.
  • Nonetheless, MRI remains an essential tool for managing patients with malignant tumors, particularly for staging these tumors prior to treatment, according to Dr. Wilson.

Transparency Notifications from Shareholders

Retrieved on: 
Thursday, February 9, 2023
FSMA, Northeast Ohio Medical University, Budget and Accounting Transparency Act of 2014, Financial Services and Markets Authority (Belgium), Financial services, Article, Person, Disclosure, Exercise, Security (finance)

(1) The total number of outstanding shares of the Company amounts to 23,746,528, each share giving right to one (1) vote (being 23,746,528 voting rights in total).

Key Points: 
  • (1) The total number of outstanding shares of the Company amounts to 23,746,528, each share giving right to one (1) vote (being 23,746,528 voting rights in total).
  • The notification furthermore specifies that Rosetta Capital is not controlled and acts as the investment manager that can exercise the voting rights at its discretion, in the absence of specific instructions.
  • This announcement is made in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions.
  • To access copies of the aforementioned transparency notifications, reference is made to Sequana Medical's website ( https://www.sequanamedical.com/investors/shareholder-information/ ).

Hims & Hers appoints first-ever Chief Pharmacy & Innovation Officer

Retrieved on: 
Monday, December 5, 2022
Pharmaceutical, Health, Telemedicine, Virtual Medicine, Children's Mercy Hospital, Publication, Hims & Hers Health, Executive, Innovation, Howard Brody, Heel, Television, United Kingdom, Cleveland, University of Minnesota College of Pharmacy, Health minister, Chief innovation officer, Cleveland Clinic, M Health Fairview University of Minnesota Medical Center, Health, Hair loss, Patient, American Pharmacists Association, Radio, MS, NYSE, Homs, Prescription, Hospital pharmacy, Mental health, Pharmacist, Multimedia, University, Dermatology, University of Kansas Medical Center, Pharming, Northeast Ohio Medical University, University of Nebraska College of Law, Foot, Management, Pharmacy, Hers

Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the companys first-ever Chief Pharmacy & Innovation Officer.

Key Points: 
  • Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the companys first-ever Chief Pharmacy & Innovation Officer.
  • View the full release here: https://www.businesswire.com/news/home/20221205005225/en/
    Dr. Scott Knoer, Chief Pharmacy & Innovation Officer at Hims & Hers (Photo: Business Wire)
    In this role, Dr. Knoer will oversee pharmacy strategy and innovation efforts for Hims & Hers.
  • The addition of Dr. Knoer as Chief Pharmacy & Innovation Officer is the next step forward for our brand, our team and our solutions, said Andrew Dudum, Chief Executive Officer at Hims & Hers.
  • I am humbled by this opportunity to help define the future of modern healthcare and wellness, said Dr. Scott Knoer, Chief Pharmacy & Innovation Officer at Hims & Hers.

Flexjet Partners with University Hospitals to Transport Pet Pals Facility Dogs to Their New Home

Retrieved on: 
Tuesday, November 29, 2022
Other Transport, Aerospace, Manufacturing, Retail, Air, Transport, Pets, Other Professional Services, Oncology, Hospitals, Luxury, Consumer, Professional Services, General Health, Health, Other Travel, Transportation, Travel, Loki, Diamond, ICAO, Transport, Pet Pals, Blue, Toxicity, University of Oxford, Sikorsky S-76, Charitable organization, Technion – Israel Institute of Technology, Case Comprehensive Cancer Center, Level, Hospital, Embraer Phenom 300, Travel medicine, Cuyahoga County Airport, PETS, Dog, Caregiver, Patient, Travel, University Hospitals Cleveland Medical Center, Animal, Gulf Stream, University, Gulfstream IV, Partnership, Golden Retriever, OH, NYSE, Male, Level 2, Bombardier, News, PetSmart, Lakeview Cabin Collection, PetSmart Charities, NCI, Hermitage Volunteer Service, U.S. News & World Report, Embraer, Multimedia, Female, Gulfstream G650, Case Western Reserve University School of Medicine, Northeast Ohio Medical University, UH, Child, Woman, Medicine, Airline, Labrador Retriever, Flexjet

Flexjet, Inc. , a global leader in subscription-based private aviation, is expanding its longstanding relationship with University Hospitals (UH) by supporting the Pet Pals Program .

Key Points: 
  • Flexjet, Inc. , a global leader in subscription-based private aviation, is expanding its longstanding relationship with University Hospitals (UH) by supporting the Pet Pals Program .
  • View the full release here: https://www.businesswire.com/news/home/20221129005649/en/
    There are only 150 facility dogs with this highly specialized training working at hospitals across the country.
  • These special dogs live with hospital staff often a doctor or a nurse and will work a 40-hour work week alongside them.
  • Pet Pals is a 501c3 nonprofit organization and relies on donations to cover the costs of the dogs, their training, transportation, etc.

Female Pelvic Health Expert Renee Caputo, M.D., Joins Central Ohio Urology Group

Retrieved on: 
Tuesday, November 1, 2022
Oncology, Health, Consumer, Hospitals, Women, Other Health, Managed Care, University, Overactive bladder, Radiation, Kent State University, Health, Pain, Urinary tract infection, Skin, Northeast Ohio Medical University, NMS, Program, Dyspareunia, BS, Pelvic floor dysfunction, Kent, Hospital, Decision-making, Gynaecology, Pelvic floor, Methodist Hospital, NEOMED, Woman, Patient, Quality of life, Female, University of Pittsburgh, Pelvic organ prolapse, Medicine, Dentistry, Medical device, Obstetrics

Central Ohio Urology Group is an affiliate of U.S. Urology Partners , one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital .

Key Points: 
  • Central Ohio Urology Group is an affiliate of U.S. Urology Partners , one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital .
  • With a clinical network of 15 offices in the region, Central Ohio Urology Group is a leading provider of comprehensive urological services , including general urology , mens health , womens health , cancer care , advanced cancer treatment and radiation oncology .
  • Corina Tracy, Chief Executive Officer of U.S. Urology Partners , the parent company of Central Ohio Urology Group , stated, We are honored to welcome such a highly respected physician as Dr. Renee Caputo to the care team at Central Ohio Urology Group.
  • To learn more about Dr. Renee Caputo or to schedule an appointment with the Central Ohio Urology Group care team , please visit www.centralohiourology.com or call (614) 396-2684.

HealthTrackRx Announces the Formation of Clinical Advisory Board with Leading Experts in Infectious Disease and Antimicrobial Resistance

Retrieved on: 
Thursday, October 13, 2022
Doctor of Pharmacy, Laboratory, Mayo Clinic, Infection, COVID, FACP, Tufts University, Pharmacist, Infectious Diseases Society of America, PCR, University, Treatment, Health, Society of Infectious Diseases Pharmacists, Pathology, Molecule, FCCP, AMR, Transplant, Individualized medicine, P, Industry, ARUP Laboratories, MHS, MACP, Summa Health, Duke University, Northeast Ohio Medical University, Society, NIH, Immunodeficiency, IDSA, ID, Master of Science, Dedicated hosting service, ASCP, Community-acquired pneumonia, Patient, American Society for Microbiology, Doctor of Philosophy, Research, Associate, Center, Pharmaceutical industry, Vaccine, Medicine, Microbiology, FIDSA, MD

DENTON, Texas, Oct. 13, 2022 /PRNewswire/ --HealthTrackRx, the nation's premier PCR diagnostic testing laboratory, today announced the formation of its Clinical Advisory Board, comprising of leading clinical experts who specialize in infectious disease (ID) and antimicrobial resistance (AMR).

Key Points: 
  • DENTON, Texas, Oct. 13, 2022 /PRNewswire/ --HealthTrackRx, the nation's premier PCR diagnostic testing laboratory, today announced the formation of its Clinical Advisory Board, comprising of leading clinical experts who specialize in infectious disease (ID) and antimicrobial resistance (AMR).
  • "We are thrilled to have these world-renowned infectious disease and antimicrobial resistance experts on our Clinical Advisory Board.
  • Insights from our Clinical Advisory Board members can help us transform infectious disease diagnostics to improve patient care, reduce healthcare costs, and combat the looming threat of antimicrobial resistance."
  • HealthTrackRx is the nation's leading PCR-based infectious disease laboratory, delivering industry-leading testing turnaround times to healthcare providers nationwide.

John J. Rush, MD, MBA, MHA, is recognized by Continental Who's Who

Retrieved on: 
Wednesday, October 12, 2022
Well, People, Linda, Physician, City, Medical degree, Business administration, Master of Business Administration, Northeast Ohio Medical University, Education, Social change, Medical school, Foundation, Patient, MBA, Multimedia, Kent State University, PAC, Knee, Emergency medicine, Loma Linda University Medical Center, MD, MHA, CEO, Awareness, Medicine, Pfeiffer University, Continental, YMCA Training, Inc. (Boston), Osteoarthritis, FDA, Master of Health Administration, View, Dentistry, Online shopping

Rush, MD, MBA, MHA, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical field and in acknowledgment of his excellence with Arthritis Knee Pain Centers.

Key Points: 
  • Rush, MD, MBA, MHA, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical field and in acknowledgment of his excellence with Arthritis Knee Pain Centers.
  • This FDA-approved injection of "visco" cushioning gels provides pain relief and improves mobility for patients without the use of opioids or surgery.
  • Arthritis Knee Pain Centers have locations in New York, New Jersey, Kentucky, Ohio, North Carolina, South Carolina, Texas, and Arizona.
  • Rush plans on opening three new medical practice locations in Georgia in the cities of Marietta, Alpharetta, and Lilburn.